Abstract
Severe thrombocytopenia in association with G-CSF therapy is extremely rare. Here we report a case of profound thrombocytopenia in a 57-year-old male with refractory cardiac ischemia, who received G-CSF during an angiogenesis trial. After 5 days of G-CSF therapy (10 μg/kg/day) the platelet count fell progressively to a nadir of 5 × 109/L. The patient received steroid, immunoglobulin and platelet support and recovered without sequelae. Subsequent investigations suggested an underlying immune-mediated thrombocytopenia, which we hypothesize was exacerbated by G-CSF therapy.
Original language | English |
---|---|
Pages (from-to) | 229-230 |
Number of pages | 2 |
Journal | American Journal of Hematology |
Volume | 82 |
Issue number | 3 |
DOIs | |
Publication status | Published - Mar 2007 |
Externally published | Yes |